comparemela.com

Latest Breaking News On - Novartis medical affairs immunology - Page 1 : comparemela.com

EC approves Novartis Cosentyx to treat arthritis in children

The European Commission (EC) has approved the extended use of Novartis’ Cosentyx (secukinumab) to treat childhood arthritic conditions.

FDA approves Novartis Cosentyx to treat arthritis in children, adolescents

Novartis received the US FDA approval for its Cosentyx to treat children and adolescents with enthesitis-related arthritis and psoriatic arthritis

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.